Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2010; Volume 200, Supplement 681
Abstracts of the 61st National Congress of the Italian Physiological Society
9/15/2010-9/17/2010
Varese, Italy


HCN RESIDUES CRITICALLY INVOLVED IN DRUG BINDING ARE IMPORTANT DETERMINANT OF CHANNEL KINETIC PROPERTIES
Abstract number: P5

BUCCHI1 A, MICHELONI1 S, NARDINI1 M, BOLOGNESI1 M, BARBUTI1 A, BARUSCOTTI1 M, DIFRANCESCO1 D

1Dept of Biomolecular Sciences and Biotechnology, Univ. of Milan, Milan, Italy

Native sinoatrial f-channels play a key role in the generation of the spontaneous electrical activity of the heart. According to this role, the inhibition of the If current by heart rate-reducing agents causes a selective reduction of the heart rate. f-channels are composed of HCN subunits, of which 4 isoforms are known; studies have identified residues of the pore regions of HCN1 and HCN2 isoforms that are critical for the binding of two members of the heart rate-reducing family: ZD7288 and cilobradine. We have identified the corresponding residues in HCN4, the main isoform expressed in the sinoatrial region, and replaced these residues by alanine (or valine), since these substitutions are normally used for investigating the role of specific residues in drug-binding mechanisms. WT and mutated channels have been heterologously expressed in HEK293 cells in order to verify by patch-clamp experiments if these mutations alter the biophysical properties of HCN4 channels. We found that the mutations A503V and Y506A induce a leftward shift of the activation curve and slow down the activation kinetics. The I510A and M508A mutations did not affect the activation curve but they did modify the activation kinetics: the I510A mutation clearly speeded up while the M508A slowed down the channel activation. This information will be useful for investigating a potential role of these residues in the binding of heart rate-reducing agents to the HCN4 channel.

To cite this abstract, please use the following information:
Acta Physiologica 2010; Volume 200, Supplement 681 :P5

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE